Agios Pharmaceuticals | Eiendeler

Assets Endring Dato
AbbVie USD 148.87B 12.65B 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Arrowhead Research USD 955.15M 328.86M 2024-03
Astellas Pharma JPY 3.37T 174.34B 2023-12
AstraZeneca USD 102.29B 1.17B 2024-03
Bayer EUR 119.88B 3.62B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Daiichi Sankyo JPY 3.27T 619.84B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
Exelixis USD 2.8B 173.16M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
Incyte USD 7.14B 353.5M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Merck USD 105.85B 878M 2024-03
Moderna USD 16.73B 1.7B 2024-03
Novartis USD 94.33B 5.61B 2024-03
Novartis USD 94.33B 5.61B 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Agios Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.